This case further extends the clinical phenotype of mutations in the MEIS2 gene and confirms the importance of genetic testing in finding the etiology of ADHD in patients who do not respond well to methylphenidate treatment and have comorbidities. The gene discussed is MEIS2; the disease is attention deficit-hyperactivity disorder.